TA Associates Invests In AIRS Medical For Global Expansion

KUALA LUMPUR, June 18 (Bernama) -- TA Associates (TA), a leading global private equity firm, has made a strategic growth investment in AIRS Medical, a global leader in artificial intelligence (AI)-powered medical imaging solutions.

In a statement, TA said the investment is aimed at accelerating AIRS Medical’s international expansion, advancing its radiology technology platform and supporting ongoing product innovation.

TA Asia Pacific Managing Director and Head, Edward Sippel said AIRS Medical has built a differentiated AI platform that addresses critical capacity and workflow challenges facing radiology providers globally.

He highlighted the company's growing presence across more than 40 countries and its position to benefit from increasing demand for imaging efficiency and diagnostic consistency.

Meanwhile, AIRS Medical co-founder and chairman, Dr Hyeseong Lee said the partnership would help the company advance its mission of improving access to advanced diagnostics while delivering greater value to healthcare providers and patients worldwide.

The investment comes as healthcare providers face mounting pressure to address rising imaging demand while maximising the utilisation of existing magnetic resonance imaging (MRI) infrastructure.

AIRS Medical's product portfolio includes SwiftMR, an AI-powered MRI acceleration and image enhancement platform, and SwiftSight, a solution for MRI quantification and structured reporting.

Financial terms of the transaction were not disclosed. The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions.

-- BERNAMA